Skip to main content

Table 3 Patient characteristics after propensity score matching

From: Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the gallbladder

 

SRC (n = 245)

Non-SRC (n = 245)

P Value

Age, years

   

 ≤ 60

56 (22.9%)

49 (20.0%)

0.441

 > 60

189 (77.1%)

196 (80.0%)

 

Sex

   

Male

59 (24.1%)

62 (25.3%)

0.753

Female

186 (75.9%)

183 (74.7%)

 

Race

   

White

194 (79.2%)

181 (73.9%)

0.097

Black

28 (11.4%)

29 (11.8%)

 

Other

23 (9.4%)

35 (11.3%)

 

AJCC stage

   

I–II

110 (44.9%)

110 (44.9%)

1.000

III–IV

73 (29.8%)

73 (29.8%)

 

Unknown

62 (25.3%)

62 (25.3%)

 

Histologic grade

   

Well-moderate

18 (7.3%)

18 (7.3%)

1.000

Poor-undifferentiated

227 (92.7%)

227 (92.7%)

 

Surgery

   

Yes

219 (89.4%)

220 (89.8%)

0.882

No

26 (10.6%)

25 (10.2%)

 

Radiotherapy

   

Yes

38 (15.5%)

30 (12.2%)

0.296

No

207 (84.5%)

215 (87.8%)

 

Chemotherapy

   

Yes

85 (34.7%)

91 (37.1%)

0.572

No

160 (65.3%)

154 (62.9%)

 

Year of diagnosis

   

1975–2009

142 (58.0%)

60 (24.5%)

 < 0.001

2010–2016

103 (42.0%)

185 (75.5%)

 

Marital status

   

Married

127 (51.8%)

119 (48.6%)

0.471

Unmarried

118 (48.2%)

126 (51.4%)

 
  1. SRC signet ring cell carcinoma, AJCC American Joint Committee on Cancer